Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001958244-24-005801
Filing Date
2024-12-02
Accepted
2024-12-02 17:07:23
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4355
  Complete submission text file 0001958244-24-005801.txt   5875
Mailing Address C/O SYROS PHARMACEUTICALS, INC. 620 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address
Simonian Nancy A (Reporting) CIK: 0001359574 (see all company filings)

Type: 144

Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340
Syros Pharmaceuticals, Inc. (Subject) CIK: 0001556263 (see all company filings)

EIN.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-37813 | Film No.: 241520016
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)